145 related articles for article (PubMed ID: 10973131)
1. A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system.
Yarzábal A; Avilán L; Hoelzl K; de Muñoz M; Puig J; Kansau I
Braz J Med Biol Res; 2000 Sep; 33(9):1015-21. PubMed ID: 10973131
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
Hajjar KA; Hamel NM
J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activation system in human milk.
Heegaard CW; Larsen LB; Rasmussen LK; Højberg KE; Petersen TE; Andreasen PA
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):159-66. PubMed ID: 9252902
[TBL] [Abstract][Full Text] [Related]
5. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
Fischer BE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
[TBL] [Abstract][Full Text] [Related]
8. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
9. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.
Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.
Pantzar M; Ljungh A; Wadström T
Infect Immun; 1998 Oct; 66(10):4976-80. PubMed ID: 9746606
[TBL] [Abstract][Full Text] [Related]
11. DDAVP induces systemic release of urokinase-type plasminogen activator.
Levi M; ten Cate JW; Dooijewaard G; Sturk A; Brommer EJ; Agnelli G
Thromb Haemost; 1989 Sep; 62(2):686-9. PubMed ID: 2510348
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
[TBL] [Abstract][Full Text] [Related]
13. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
[TBL] [Abstract][Full Text] [Related]
15. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
16. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator.
Andrade-Gordon P; Strickland S
J Biol Chem; 1989 Sep; 264(26):15177-81. PubMed ID: 2504719
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
Hayashi K; Nakashima Y; Sueishi K; Tanaka K
Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
[TBL] [Abstract][Full Text] [Related]
19. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
20. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
Krause J; Seydel W; Heinzel G; Tanswell P
Biochem J; 1990 May; 267(3):647-52. PubMed ID: 2160232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
